PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 619431

Retractile mesenteritis: initial presentation as colonic obstruction.

R G Williams·J A Nelson
View original source ↗Export metadata ↓

Abstract

Retroperitoneal fibrosis has been associated with a variety of sclerosing diseases. Among these is the variant known as retractile mesenteritis, which involves predominantly the mesentery of the small intestine and associated vessels; involvement of the mesocolon and the colon is less frequent. Two patients with a dominating clinical picture of colonic obstruction are described. The radiographic presentations were similar and should serve to remind radiologists and clinicians of this entity.

Explore related subjects

Colonic DiseasesDiagnosis, DifferentialFemaleHumansIntestinal ObstructionMaleMesenteryMiddle AgedPeritonitisRadiographyRetroperitoneal FibrosisCase ReportsJournal ArticleResearch Support, U.S. Gov't, P.H.S.

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R G Williams, J A Nelson. 1978. Retractile mesenteritis: initial presentation as colonic obstruction.. https://doi.org/10.1148/126.1.35

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2012

Crohn's disease.

Crohn's disease is a relapsing systemic inflammatory disease, mainly affecting the gastrointestinal tract with extraintestinal manifestations and associated immune disorders. Genome wide association studies identified susceptibility loci that--triggered by environmental factors--result in a disturbed innate (ie, disturbed intestinal barrier, Paneth cell dysfunction, endoplasmic reticulum stress, defective unfolded protein response and autophagy, impaired recognition of microbes by pattern recognition receptors, such as nucleotide binding domain and Toll like receptors on dendritic cells and macrophages) and adaptive (ie, imbalance of effector and regulatory T cells and cytokines, migration and retention of leukocytes) immune response towards a diminished diversity of commensal microbiota. We discuss the epidemiology, immunobiology, amd natural history of Crohn's disease; describe new treatment goals and risk stratification of patients; and provide an evidence based rational approach to diagnosis (ie, work-up algorithm, new imaging methods [ie, enhanced endoscopy, ultrasound, MRI and CT] and biomarkers), management, evolving therapeutic targets (ie, integrins, chemokine receptors, cell-based and stem-cell-based therapies), prevention, and surveillance.

Colonic Diseases↗